Terry Gould

Terry invests in venture and growth-oriented companies with a focus on the healthcare space. Terry sits on the Board of Directors of Aptinyx, Atox Bio, Corvus, Fusion Pharmaceuticals, Orbus, Outpost Medicine, Partner Therapeutics, and Qpex. He is a Board Observer at Millendo. He is a former Board Member at CombiChem, INC Research, Incline Therapeutics, and Proteus Digital Health. He is responsible for several other successful investments including Heartport, Jazz Pharmaceuticals, Naurex Pharmaceuticals, NxStage Medical, Pharmacyclics, Rempex Pharmaceuticals, Revivant, Spinal Dynamics, and Vivant Medical.

Terry is a Senior Partner, Growth Equity of the Adams Street Partners Growth Equity Investment Committee, as well as a member of the firm's Co-Investment Committee and Executive Committee.

Terry Gould is the Senior Partner, Growth Equity at Adams Street Partners, based in United States, North America. With a background in Financial Services, Terry Gould has a rich history of leadership and innovation. Terry Gould studied BA unknown @ Dartmouth College. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.